Author | Linda Peckel


Some Scleroderma Patients are Protected from Cancer

July 28, 2019

Researchers writing in Arthritis and Rheumatology have found that some scleroderma patients carry enriched antibodies that may prevent cancer and provide immunity to other systemic sclerosis-associated conditions, such as scleroderma renal crisis and SSc-gastrointestinal disease.

Understanding the Role of Polyautoimmunity in Rheumatic Diseases

July 16, 2019

An estimated 5 percent of the world’s population is diagnosed with one of a group of heterogeneous autoimmune rheumatic diseases (ARDs) including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and Sjogren’s syndrome (SS). Not only do these diseases share mechanisms and risk factors, they are often comorbid conditions recognized as polyautoimmune (PolyA) manifestations of the same underlying dysfunction.

Highlights from LUPUS 2019

July 09, 2019

New results for baricitinib and ustekinumab use in patients with systemic lupus erythematosus (SLE) were presented in April at the International Congress on Systemic Lupus Erythematosus (LUPUS 2019), which was held in San Francisco. Here, we summarize those results, plus much more from the meeting.

Q&A: Dr. Jim Oates on Hard-to-Treat Lupus in Black Patients

July 09, 2019

The prevalence of systemic lupus erythematosus (SLE) is higher among black patients. They can present with a worsened disease state and mortality rates can be higher. This suggests a need for better therapeutic options, says Jim C. Oates, M.D., of Medical University of South Carolina. In this Q&A, Dr. Oates addresses treatment challenges black patients face.